[125] During suppressive therapy, recurrent BV occurred in 13 women (25.5%) receiving metronidazole and in 26 (59.1%) receiving placebo (RR: 0.43; 95% CI: 0.25–0.73%; p = 0.001). During the ...

Wisp, the largest pure play women's telehealth company in the U.S. focused on providing sexual and reproductive health ...

That fishy smell? It’s bacterial vaginosis. A new study shows it’s an STI, and male partners should be treated to stop the ...

Hirsch said doctors in the U.S. would likely use the same first-line BV medications—metronidazole and clindamycin gel—to ...

Bacterial vaginosis is common and associated with adverse obstetric and gynecologic outcomes, yet much is unknown about its pathogenesis. After current first-line treatment -- metronidazole or ...

Bacterial vaginosis (BV) is one of the most common vaginal infections, yet many women have never even heard of it. It affects about one-in-three women globally, making it more common ...

BV affects roughly 21 million women in the ... couples to a group in which the male partner was treated with 400 mg of metronidazole and a topical clindamycin cream. They assigned 83 couples ...

In this randomized controlled trial, female patients with bacterial vaginosis (BV) had lower recurrence rates when their male ...

BV infection may develop following exposure ... and male partners received combined oral and topical antimicrobial therapy (metronidazole 400-milligram tablets and 2% clindamycin cream applied ...

Therapy of BV typically involves treatment with oral or intravaginal metronidazole or clindamycin and is associated with particularly high relapse rates. Alternative treatment options ...

The standard treatment approach is to take a pill (metronidazole) or to insert an antibiotic cream directly into the vagina for 5-7 days. Researchers have believed for many years that BV might be ...